And the one on the right is the 1984 one
However, specific CNS opioid receptors for endogenous compounds with opioid-like activity have been identified throughout the brain and spinal cord and are thought to play a role in the analgesic effects of this drug
94:1313-1319 (2012) Hosaka K, Nikawa J-i, Kodaki T, Yamashita S
Diabetes Complications 38 , 108631 (2024)
This article explores what BPC-157 is, what the research actually shows about its effects on the gut, and why gastrointestinal health may be a criticalbut often overlookedfactor in metabolic health and weight regulation
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760
